{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T03:25:58Z","timestamp":1785209158395,"version":"3.55.0"},"reference-count":15,"publisher":"Endocrinology Research Centre","issue":"4","license":[{"start":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T00:00:00Z","timestamp":1631750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.probl-endojournals.ru\/jour\/about\/editorialPolicies#openAccessPolicy"}],"content-domain":{"domain":["www.probl-endojournals.ru"],"crossmark-restriction":true},"short-container-title":["Probl Endokrinol (Mosk)"],"abstract":"<jats:p>The most important and effective way to organize nationwide the healthcare, as well as monitoring and routing for patients with endocrine diseases, is the creation of an unified medical record (Endocard). The Endocard is also aimed at maximizing the opportunity for professionals and researchers on various scientific issues. Registries are the potential informational and analytical platform to achieve this goal. They include the basic information on the epidemiological and clinical features of the most severe diseases such as diabetes mellitus. Given the lack of large-scale epidemiological data on the parathyroid glands pathology \u2014 primary hyperparathyroidism and hypoparathyroidism \u2014 the registers of these diseases that collects a common dataset and clinician and patient reported outcomes are of particular interest.<\/jats:p>","DOI":"10.14341\/probl12803","type":"journal-article","created":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T05:38:19Z","timestamp":1631857099000},"page":"4-7","update-policy":"https:\/\/doi.org\/10.14341\/crossmarkpolicy2018","source":"Crossref","is-referenced-by-count":9,"title":["Registries of parathyroid glands diseases in the Russian Federation"],"prefix":"10.14341","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9717-9742","authenticated-orcid":true,"given":"N. G.","family":"Mokrysheva","sequence":"first","affiliation":[{"name":"Endocrinology Research Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9258-2591","authenticated-orcid":true,"given":"E. V.","family":"Kovaleva","sequence":"additional","affiliation":[{"name":"Endocrinology Research Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6667-062X","authenticated-orcid":true,"given":"A. K.","family":"Eremkina","sequence":"additional","affiliation":[{"name":"Endocrinology Research Center"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5458","published-online":{"date-parts":[[2021,9,16]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Bilezikian JP, Brandi ML, Eastell R, et al. Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: Summary Statement from the Fourth International Workshop. J Clin Endocrinol Metab. 2014;99(10):3561-3569. doi: https:\/\/doi.org\/10.1210\/jc.2014-1413","DOI":"10.1210\/jc.2014-1413"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Dedov II, Melnichenko GA, Mokrysheva NG, et al. Primary hyperparathyroidism: the clinical picture, diagnostics, differential diagnostics, and methods of treatment. Problems of Endocrinology. 2017;62(6):40-77. doi: https:\/\/doi.org\/10.14341\/probl201662640-77","DOI":"10.14341\/probl201662640-77"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Paik JM, Curhan GC, Taylor EN. Calcium intake and risk of primary hyperparathyroidism in women: prospective cohort study. BMJ. 2012;345:e6390-e6390. doi: https:\/\/doi.org\/10.1136\/bmj.e6390","DOI":"10.1136\/bmj.e6390"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Wermers RA, Khosla S, Atkinson EJ, et al. Incidence of Primary Hyperparathyroidism in Rochester, Minnesota, 1993-2001: An Update on the Changing Epidemiology of the Disease. J Bone Miner Res. 2005;21(1):171-177. doi: https:\/\/doi.org\/10.1359\/JBMR.050910","DOI":"10.1359\/JBMR.050910"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Yu N, Donnan PT, Murphy MJ, Leese GP. Epidemiology of primary hyperparathyroidism in Tayside, Scotland, UK. Clin Endocrinol (Oxf ). 2009;71(4):485-493. doi: https:\/\/doi.org\/10.1111\/j.1365-2265.2008.03520.x","DOI":"10.1111\/j.1365-2265.2008.03520.x"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Kukora JS, Zeiger MA, Clark OH, et al. The American Association of Clinical Endocrinologists and The American Association of Endocrine Surgeons Position Statement on The Diagnosis and Management of Primary Hyperparathyroidism. Endocr Pract. 2005;11(1):49-54. doi: https:\/\/doi.org\/10.4158\/EP.11.1.49","DOI":"10.4158\/EP.11.1.49"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Bone HG, Wagman RB, Brandi ML, et al. 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and openlabel extension. Lancet Diabetes Endocrinol. 2017;5(7):513-523. doi: https:\/\/doi.org\/10.1016\/S2213-8587(17)30138-9","DOI":"10.1016\/S2213-8587(17)30138-9"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Pepe J, Cipriani C, Sonato C, et al. Cardiovascular manifestations of primary hyperparathyroidism: a narrative review. Eur J Endocrinol. 2017;177(6):R297-R308. doi: https:\/\/doi.org\/10.1530\/EJE-17-0485","DOI":"10.1530\/EJE-17-0485"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Khan AA, Hanley DA, Rizzoli R, et al. Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus. Osteoporos Int. 2017;28(1):1-19. doi: https:\/\/doi.org\/10.1007\/s00198-016-3716-2","DOI":"10.1007\/s00198-016-3716-2"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Mokrysheva NG, Mirnaya SS, Dobreva EA, et al. Primary hyperparathyroidism in Russia according to the registry. Problems of Endocrinology. 2019;65(5):300-310. (In Russ.) doi: https:\/\/doi.org\/10.14341\/probl10126","DOI":"10.14341\/probl10126"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Bollerslev J, Rejnmark L, Marcocci C, et al. European Society of Endocrinology Clinical Guideline: Treatment of chronic hypoparathyroidism in adults. Eur J Endocrinol. 2015;173(2):G1-G20. doi: https:\/\/doi.org\/10.1530\/EJE-15-0628","DOI":"10.1530\/EJE-15-0628"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Khan AA, Koch CA, Van Uum S, et al. Standards of care for hypoparathyroidism in adults: a Canadian and International Consensus. Eur J Endocrinol. 2019;180(3):P1-P22. doi: https:\/\/doi.org\/10.1530\/EJE-18-0609","DOI":"10.1530\/EJE-18-0609"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"David K, Moyson C, Vanderschueren D, Decallonne B. Long-term complications in patients with chronic hypoparathyroidism: a cross-sectional study. Eur J Endocrinol. 2019;180(1):71-78. doi: https:\/\/doi.org\/10.1530\/EJE-18-0580","DOI":"10.1530\/EJE-18-0580"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Bilezikian JP, Khan A, Potts JT, et al. Hypoparathyroidism in the adult: Epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research. J Bone Miner Res. 2011;26(10):2317-2337. doi: https:\/\/doi.org\/10.1002\/jbmr.483","DOI":"10.1002\/jbmr.483"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Kovaleva EV, Ajnetdinova AR, Eremkina AK, Mokrysheva NG. Evaluation of chronic hypoparathyroidism course according to the Database of Endocrinology Research Centre. Problems of Endocrinology. 2020;66(5):7-14.(In Russ.) doi: https:\/\/doi.org\/10.14341\/probl12675","DOI":"10.14341\/probl12675"}],"container-title":["Problems of Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.probl-endojournals.ru\/jour\/article\/viewFile\/12803\/9955","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T05:41:24Z","timestamp":1631857284000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.probl-endojournals.ru\/jour\/article\/view\/12803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,16]]},"references-count":15,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,9,16]]}},"URL":"https:\/\/doi.org\/10.14341\/probl12803","relation":{},"ISSN":["2308-1430","0375-9660"],"issn-type":[{"value":"2308-1430","type":"electronic"},{"value":"0375-9660","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9,16]]}}}